[1] |
ZHANG Wenhai, LIAN Bin, HOU Qinhan, LIANG Xinguang, YANG Qiujiao, LIANG Ling, CHEN Binjie, WEI Changyuan.
Construction and validation of nomogram model for predicting the relatively long-term survival of metastatic breast cancer based on SEER database
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 454-461.
|
[2] |
LUO Xianting, FENG Yimin, ZHOU Jing, XIAO Lei, YIN Jiayu, ZHAO Xin, SU Danke.
Value of Kaiser score-based MRI feature nomogram model in preoperative prediction of vascular invasion in mass breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 332-338.
|
[3] |
LI Ting, LI Qian, LI Yongqiang, LIAO Xiaoli.
Analysis of prognostic factors for patients with mismatch repair?proficient advanced colorectal cancer treated by immunotherapy combined with targeted therapy and its prediction nomogram construction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 215-222.
|
[4] |
ZHANG Zhihong, CUI Wangfei, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Prediction model of high-risk population of upper gastrointestinal cancer and precancerous lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 549-555.
|
[5] |
QIU Jialin, LIANG Shixiong, LI Jianxu, QIU Moqin, LONG Meiying, JIANG Yanji, HE Meiling, WEI Xueyan, YU Hongping.
Prognostic factors for hepatocellular carcinoma of China liver cancer staging Ⅲ after radiotherapy and prediction nomogram construction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 195-201.
|
[6] |
LIN Xiaowan, LI Xiang, DU Chi.
Development of a prognostic model for radical resection of locally⁃advanced oral squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(4): 412-418.
|
[7] |
QIN Jianlun, LU Huayong, WU Panxuan, WEI Jiu.
Application of different hepatic blood flow occlusion methods in liver cancer resection
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 189-193.
|
[8] |
ZHANG Lei, ZHAO Xiulei, KONG Deshuai, LI Jinchao, WANG Zhenyong, LIU Ruhai, CHAI Wei.
Construction and verification of the prognosis evaluation model for patients in hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy based on the nomogram
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 518-523.
|
[9] |
ZHOU Yongxing, TAN Guanqiao, ZHOU Dawei.
Construction and application of an early recurrence prediction model for pancreatic head cancer after radical pancreaticoduodenectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 523-528.
|
[10] |
WEI Yingting, QIN Jiameng, FAN Jinlian, LIANG Min, ZHOU Haihua, HUI Dong, LI Ting.
Deep learning - based development and validation of a predictive model for evaluating the prognosis of hepatocellular carcinoma: A study of a large-sample cohort and external validation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 294-300.
|
[11] |
LUO Shanhui, ZHU Weipei.
Development of a prognostic nomogram and risk stratification system for cervical carcinoma after operation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 560-565.
|
[12] |
TANG Zhihong, YUAN Du, CHEN Zhiwei, MENG Weida, WU Feixiang, WANG Xiaobo.
Value of the aspartate aminotransferase to lymphocyte ratio in evaluating prognosis of primary liver cancer with portal vein tumor thrombus patients before TACE
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 572-577.
|
[13] |
CHEN Zhiwei, WU Feixiang, CHEN Jie, WANG Xiaobo, TANG Zhihong, MENG Weida, WEI Meng, ZHANG Lianda, MAI Rongyun, WEI Tao, SU Hengfeng, LI Lequn, BAI Tao.
Development and evaluation of a predictive model for primary liver cancer recurrence after radiofrequency ablation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 63-69.
|
[14] |
PENG Ning, TAO Yiwen, HENG Songqing, YANG Hong, SHANG Liming, XIAO Kaiyin.
Ultrasound guided fusion virtual CT navigation radiofrequency therapy for high risk sites of primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 412-415.
|
[15] |
WANG Huifeng, CHEN Jie, LUO Tao, CHEN Miao, ZHAO Yuan, WANG Duo, LI Lequn.
Effect of Hsa-miR-4282 on the growth of hepatoma cell line SMMC-7721
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(2): 126-131.
|